by Talking Medicines | Sep 29, 2022
Women’s health issues, from the menopause to periods, have traditionally been under-represented in public health discourse and frequently are lacking media and marketing profile. However, in recent months women’s health issues have become far more visible, partly due...
by Talking Medicines | Sep 29, 2022
Left to Right: Nicola Johnson – AVP Customer Success, Jo Halliday – CEO, Elizabeth Fairley – COO We are delighted that Talking Medicines has been shortlisted in our home market by Women’s Enterprise Scotland as...
by Talking Medicines | Aug 17, 2022
As a technology business with a focus on providing pharma marketers with data-based patient intelligence, it’s vital that we stay on top of the big news and trends driving pharma marketing. One of the ways we do this is by following pharma marketing...
by Talking Medicines | Aug 16, 2022
ESG, or Environmental, Social and Governance can often be seen as the soft underbelly of business. A series of aspirational, yet vague goals which may appear to have little or no direct impact on ‘hard-headed business’ – especially in today’s competitive...
by Talking Medicines | Aug 10, 2022
Changing market Consumers are changing. Their expectations are higher, and it is becoming ever more difficult for brands to stand out amongst the noise of competitors. With 80% of consumers now saying they would be more likely to make a purchase from a brand...
